News | March 23, 2023
Emmes acquires Essex Management
Essex enriches and complements Emmes’ services
Essex enriches and complements Emmes’ services
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
Twelve hospitals across India will be part of the network which will support the trial in India
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
There is a great opportunity for utilizing traditional medical practices like Ayurveda in Value Based Healthcare
The AGE1.CR.pIX cell line is derived from primary cells of a duck embryo and was designed to comply with health authority guidelines
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
Partnership to leverage the Helix Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Subscribe To Our Newsletter & Stay Updated
